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The mechanisms whereby feline immunodeficiency virus (FIV) adsorbs and enters into susceptible cells are poorly understood. Here, we
investigated the role exerted in such functions by the tryptophan (Trp)-rich motif present membrane-proximally in the ectodomain of the FIV
transmembrane glycoprotein. Starting from p34TF10, which encodes the entire genome of FIV Petaluma, we produced 11 mutated clones
having the Trp-rich motif scrambled or variously deleted or substituted. All mutated progenies adsorbed normally to cells, but the ones with
severe disruptions of the motif failed to generate proviral DNA. In the latter mutants, proviral DNA formation was restored by providing an
independent source of intact FIV envelope glycoproteins or by addition of the fusing agent polyethylene glycol, thus clearly indicating that
their defect resided primarily at the level of cell entry. In addition, the replication-competent mutants exhibited a generally enhanced
susceptibility to selected entry inhibitory synthetic peptides, suggestive of a reduced efficiency of the entry step.
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Feline immunodeficiency virus (FIV) is a naturally occur-
ring lentivirus (Pedersen et al., 1987) that resembles the
human immunodeficiency virus (HIV) under many respects
and is intensively studied both as a natural pathogen of
domestic cats and as a model system for HIV pathogenesis
and immunobiology (reviewed in Elder and Phillips, 1995;
Elder et al., 1998; Willett et al., 1997a). However, the
process of host cell entry by FIV is still poorly understood.
For example, the viral and cellular structures that mediate
FIV binding to the cell surface are poorly characterized (de
Parseval and Elder, 2001; Frey et al., 2001; Willett et al.,
2003). On the cell side, CXCR4 is certainly involved in FIV
binding but it remains unresolved whether this chemokine
receptor represents the primary receptor, as observed with0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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just a co-receptor, as is the case for most strains of these
viruses (Egberink et al., 1999; Richardson et al., 1999;
Willett et al., 1997b). On the virus side, the early interactions
with cells are believed to be mediated like in other lentivi-
ruses by the viral envelope (Env), through glycoprotein
complexes formed by the surface (SU) glycoprotein or
gp95 and by the transmembrane glycoprotein (TM) or
gp36, which result from proteolytic cleavage of a heavily
glycosylated precursor polypeptide (Elder and Phillips,
1995). In the case of HIV, it is generally accepted that the
glycoprotein complexes are associated in trimers on the viral
surface and that interaction of SU with the cell receptor CD4
and one co-receptor molecule triggers a complex chain of
conformational rearrangements in the TM that lead to the
insertion of its hydrophobic amino-terminal fusion peptide
into the target cell membrane and to the ultimate fusion of
this with the viral Env with the consequent delivery of the
nucleocapsid into the cytoplasm (Chan and Kim, 1998;
Doms and Moore, 2001; Overbaugh et al., 2001; Wyatt
and Sodroski, 1998). Although it seems likely that the FIV
S. Giannecchini et al. / Virology 320 (2004) 156–166 157Env is organized in a similar manner (Pancino et al., 1993,
1995; Serres, 2000) and performs entry by similar molecular
mechanisms (de Parseval and Elder, 2001; Frey et al., 2001),
information available on these aspects is very scanty, and
significant differences with HIV cannot be excluded.
The TM glycoproteins of numerous enveloped viruses,
including lentiviruses, present an unusual clustering of the
otherwise relatively rare aromatic amino acid tryptophan
(Trp) in the region that is immediately external to their
membrane-spanning domains (Sua´rez et al., 2000a). This
has led to hypothesize an essential role for this region in the
functions exerted by this class of molecules, including
membrane fusion and cell entry (Sua´rez et al., 2000a,
2000b, and reviewed in Peisajovich and Shai, 2003). In fact,
mutagenesis studies have clearly shown that certain deletions
or disruptions of the Trp-rich region abrogate the fusogenic
effects of HIV and block entry, although other modifications
substantially reduce the efficiency of these processes
(Mun˜oz-Barroso et al., 1999; Salzwedel et al., 1999). The
Trp-rich motif of FIV consists of three equally distanced Trp
residues located at positions 770, 773, and 776 (amino acid
positions starting with the first Met of Env; Talbott et al.,
1989), which are conserved in all the isolates hitherto
sequenced (Rigby et al., 1993). That this pre-transmembrane
motif could be important for FIV entry was recently sug-
gested by findings showing that a synthetic peptide modeled
on such motif inhibited FIV replication very efficiently, most
likely by blocking entry, and that the inhibitory effect was
dependent on conservation of all three Trp residues (Gian-
necchini et al., 2003).
In this study, we have more directly addressed the role of
the Trp motif of FIV in cell entry by investigating how
effectively molecular clones carrying deletions or substitu-
tions in this motif adsorb to and enter susceptible cells. The
results have clearly shown that integrity of the Trp motif is
not required for efficient FIV adsorption to cells but is
important for optimal FIVentry. The data have also indicated
that at least during short-term replication in vitro FIV can
tolerate a substantial degree of change within the Trp motif
without major losses in replication capacity. However, all the
mutants that conserved replication competence exhibited an
increased sensitivity to two FIV entry inhibitors thought to
target sites of the TM other than the Trp motif, suggesting
that they might be at disadvantage relative to wild-type (WT)
virus when the efficiency of entry is a critical factor. A better
understanding of these aspects may help design improved
fusion inhibitors and immunogens exploitable for FIV ther-
apy and prophylaxis.Results
Mutants developed
To investigate the contribution of the Trp motif W770–I777
within the intact FIV virion, we produced deletion andalanine (Ala) substitution mutants in this domain of the
Petaluma strain of FIV (FIV-Pet) by using site-directed
mutagenesis. The starting construct was a derivative of
p34TF10 (Talbott et al., 1989), developed for a previous
study (Bendinelli et al., 2001), that had had the stop codon at
position 6210 of the open reading frame A removed to render
the encoded FIV capable of replicating in feline lymphoid
cells as well as in fibroblastoid Crandell feline kidney
(CrFK) cells. This was further modified by substituting the
entire env gene with the corresponding gene of a line of FIV-
Pet that, after prolonged growth in chronically infected FL4
cells, had been readapted to grow in cats, thus reacquiring
many features of primary FIV isolates (Bendinelli et al.,
2001). The construct thus prepared (wild-type, WT) was
finally used to produce 11 mutants (Fig. 1): of these, one had
the Trp motif scrambled (clone Scr), three contained dele-
tions of 4, 8, or 12 amino acids within the Trp motif (clones
D4, D8, and D12), and seven had 1, 2, or all the 3 Trp
residues present in this motif substituted with Ala.
Expression of the mutated constructs after transfection
Ten micrograms of the WT and mutated constructs were
transfected into 5  105 CrFK cells, which were then
supplemented with 106 cells of the feline lymphoid MBM
line and monitored for virus production by measuring the
reverse transcriptase (RT) activity released in the culture
fluids at intervals for 1 month. As shown by Fig. 2, in the
early days after transfection, all of the cultures released
variable levels of RT. However, at later times, the curves
of RT production differed markedly depending on the
construct transfected. In particular, the cultures transfected
with the WT construct accumulated RT in the supernatant
fluid throughout the observation period. In contrast, the
cultures transfected with the mutants having the Trp motif
scrambled or more or less extensively deleted exhibited a
rapid decline and disappearance of RT activity. On the other
hand, the Ala-substituted mutants showed RT production
curves that differed depending on how many and which Trp
residues were substituted: W770A and W776A generated RT
curves indistinguishable from the WT control, W773A, W773/
776A, and W770/776A accumulated RT progressively but at
reduced rates, and W770/773A and W770/773/776A, after the
initial spell of RT production mentioned above, no longer
exhibited detectable enzyme activity, thus behaving similarly
to the scrambled or deleted constructs.
Characterization of the viral progenies generated by the
mutated constructs
In the above study, all of the transfected cultures had
reacted positive for RT activity at day 5, but only some were
still RT positive at later times, indicating that all the
constructs had generated viral particles for at least some
time following transfection, but that the viral progenies
produced by some clones were unable to maintain a sus-
Fig. 2. RT activity generated by the WT and mutated constructs of Fig. 1 following transfection into permissive cell cultures. CrFK cells (5  105) were
transfected with 10 Ag of each molecular clone as indicated under Material and methods and immediately supplemented with 106 MBM cells. RT activity in the
supernatant fluids was monitored at the indicated times. OD, optical density.
Fig. 1. Schematic representation of the mutated constructs produced for this study. The locations within the FIV TM gp of the investigated Trp motif 770–781
and of the inhibitory TM-derived synthetic peptides (Giannecchini et al., 2003) used in the study are shown. Superscript figures denote amino acid positions
starting with the first methionine of Env, according to the sequence of FIV-Pet, clone 34TF10 (Talbott et al., 1989). TM domains are indicated as previously
described (Richardson et al., 1998): FC, fusion peptide; , leucine zipper region; C–C, cysteine loop; , membrane-proximal a-helix; , membrane-spanning
segment; Cyto, cytoplasmic region. Dashes and underlined A represent the deletions introduced and the Trp residues substituted by an Ala, respectively.
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Fig. 3. Electrophoretic mobility of the viral components generated by Trp
motif-mutated clones. The virus-containing day 5 supernatants of trans-
fected cultures were pelleted, electrophoresed on 10% SDS-PAGE, and then
probed with FIV-immune cat serum (upper panel) or the anti-FIV Env
monoclonal antibody 71.2 (lower panel), followed by peroxidase
conjugated anti-feline and anti-mouse IgG polyclonal antibody. The
positions of three major FIV components are indicated to the left.
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clusions, we characterized the day 5 cultures further. Table 1
shows that irrespective of the construct used for transfection,
all cultures contained FIV p25 capsid protein, FIV genomes,
and FIV Env. Moreover, immunoblotting analysis showed
that the electrophoretic mobilities and relative proportions of
the principal FIV structural components present in the super-
natants of all the cultures were similar and typical of what
observed with intact virions (Fig. 3). When, however, the day
5 cultures were tested for FIV infectivity by inoculation into
fresh MBM cells, a major difference emerged. In fact, the
ones that had been transfected with constructs having the Trp
motif deleted, scrambled, or Ala-substituted at both positions
770 and 773 or at all three Trp positions failed to infect, no
matter whether the inoculation of fresh cells was carried with
cell-free supernatant or viable cells (Table 1). In contrast, the
others readily and consistently infected (Table 1) and did so
at titers that ranged around 102 50% tissue culture infectious
doses (TCID50) per milliliter of supernatant (data not
shown). Because CrFK cells may express large quantities
of the endogenous retrovirus RD114 (Baumann et al., 1998),
the possibility was also considered that replication of some
mutants was the result of phenotypic mixing with Env from
such virus. To this purpose, the replicative mutants were
tested for neutralizability by a powerful anti-RD114 Env
serum (kind gift of Dr. Brian Willett, Glasgow, UK) and, in
parallel, by serum from FIV-Pet-infected cats. Although theTable 1
Characteristics of the progeny virus generated by the TM clones on day 5
post-transfection of CrFK cellsa
Clone FIV FIV FIV Infectivitye
capsid
proteinb
Envc genomesd
Cell-free Cell-
associated
WT >2.500 + 1.7  108 + +
Scr >2.500 + 2.0  108  
D4 >2.500 + 1.7  108  
D8 >2.500 + 1.7  108  
D12 2.354 + 1.5  108  
W770A >2.500 + 2.5  108 + +
W773A >2.500 + 2.0  108 + +
W776A >2.500 + 2.2  108 + +
W770/773A >2.500 + 1.2  108  
W770/776A >2.500 + 2.1  108 + +
W773/776A >2.500 + 2.1  108 + +
W770/773/776A 2.100 + 1.8  108  
a Results of one representative experiment out of three performed.
b Optical density (OD) at 450 nm in the enzyme-linked immunosorbent
assay (ELISA) used for p25 detection.
c The day 5 supernatants were incubated in Galanthus nivalis lectin coated
wells that were then reacted with pooled serum from six FIV-infected cats.
d No of genomes per milliliter of supernatant, as measured by real time Taq-
Man-PCR (rt-TM-PCR).
e One hundred microliters of the supernatants normalized for p25 content, or
105 transfected CrFK cells were incubated with 105 MBM cells at 37 jC for
24 h. After extensive washing, the cells were then cultured in fresh medium.
Virus production was determined by measuring p25 at day 8, when the
cultures were terminated.latter effectively blocked the growth of all the mutants, the
anti-RD114 serum had no detectable effects on any (results
not shown), thus excluding that phenotypic mixing permitted
their replication. On day 5 post-transfection and, for the
cultures that were still RT positive, also at the end of the 1-
month observation period, we also amplified and sequenced
the env genes, detecting no changes relative to the input
constructs (data not shown). Collectively, these findings
confirmed that (1) early after transfection into permissive
cells, all the constructs had indeed produced and released
comparable numbers of physicochemically indistinguishable
progeny virions, regardless of the changes they carried in the
Trp motif, and (2) the viral particles generated by the
constructs having the Trp motif deleted, scrambled, or Ala-
substituted at both positions 770 and 773 or at all three Trp
positions were indeed replication-incompetent.
Ability of the mutated viral progenies to adsorb to and enter
susceptible cells
In these experiments, we examined whether the failure to
replicate of some Trp motif mutants could be due to impaired
adsorption or entry into cells. Adsorption was investigated
by incubating the day 5 supernatant fluids diluted to contain
107 FIV genome copies per milliliter with 5  105 MBM
cells at 4 jC for 2 h, that is, under conditions known to
permit virus adsorption but not entry into cells (de Parseval
and Elder, 2001; Giannecchini et al., 2002). At the end of the
incubation period, the cells were then washed 4 times with
abundant phosphate-buffered saline and tested for FIV RNA
content as a measure of the viral particles that had become
Fig. 4. Ability of the Trp motif-mutated progeny viruses to bind to (A) and
enter permissive cells (B). In (A), 1-ml aliquots of the virus-containing
supernatants harvested from the transfected cultures at day 5 were
normalized to contain 107 FIV genome copies and incubated with 5 
106 MBM cells at 4 jC for 2 h. The cells were then extensively washed and
examined for bound FIV RNA copies by quantitative rt-TM-PCR. The
results are expressed as numbers of viral RNA copies found associated to
the cells. The lower binding of some mutants relative to the WT was
considered not significant in view of inconsistency in independent
experiments. In (B), the cells were exposed to the virus containing
supernatants as above but incubated at 37 jC for 24 h. The cells were then
extensively washed and examined for proviral FIV DNA copies by
quantitative rt-TM-PCR. The results are expressed as numbers of viral
DNA copies found associated to the cells. Specificity of adsorption is
demonstrated by failure to bind of sonicated WT progeny.
Fig. 5. Effect of PEG on provirus generation by the nonreplicative Trp
motif mutants. The virus containing supernatants harvested from the
transfected cultures at day 5 were normalized to contain 107 viral RNA
copies per milliliter and mixed with 106 MBM cells. The mixtures were
then immediately treated with PEG (25% final concentration, n) or left
untreated (5) and incubated at 37 jC. After 24 h, the cells were extensively
washed and examined for proviral FIV DNA copies by quantitative rt-TM-
PCR.
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sonicated WT virus used as a negative control was totally
unable to adsorb to the substrate cells, all the Trp motif-
mutated viral progenies absorbed as numerous or only
slightly less so than the WT progeny. This clearly indicated
that the Trp motif was largely, if not completely, dispensable
for efficient FIV binding to cells.
Entry was investigated by exposingMBM cells to the viral
progenies exactly as above, except that incubation was
carried out at 37 jC, a temperature known to permit virus
entry as well as virus adsorption, and extended for 24 h to
permit the formation of FIV provirus (Giannecchini et al.,
2002). The amount of virus that had gained access into the
cells was then evaluated by enumerating the viral DNA
copies associated with the cells. As shown by Fig. 4B, all
the mutant viral progenies that had proven noninfectious in
the above experiments also failed to generate detectableproviral DNA. Conversely, all the replication-competent
mutants led to the appearance of proviral DNA in the cells.
However, some of the latter generated fewer provirus copies
than the WT control, partly paralleling what observed above
with regard to the virus replication curves generated by the
constructs (Fig. 2). It was thus inferred that the Trp motif
mutations that had impaired FIV replication had done so by
blocking or reducing the efficiency of a step that was
subsequent to adsorption and that permitted retrotranscription
of the viral genome, most likely virus entry. That the block
was indeed at the level of cell entry was corroborated by
experiments in which the nonreplicative mutants were incu-
bated with MBM cells in the presence of 25% polyethylene
glycol 6000 (PEG). As shown by Fig. 5, in the presence of
this fusogenic agent, all the mutants that had failed to do so
under standard conditions generated substantial copy numb-
ers of proviral DNA, albeit less effectively than the WT, thus
showing that they were still capable of performing the steps
subsequent to cell entry.
Complementation of mutant D12 with a plasmid encoding
intact FIV Env
To determine whether the loss of infectivity brought about
by certain Trp motif mutations in the above studies was
indeed solely the consequence of a nonfunctional Env, we
investigated whether their replication was restored by an
independent source of intact FIV Env. Construct D12 was
chosen for the study because of its extensive Trp motif
deletion. This construct was mixed with a plasmid contain-
ing the intact env gene of FIV-Pet or with an irrelevant
plasmid at equimolecular ratios, and the mixtures were
transfected into CrFK cells that were then processed exactly
Fig. 6. Complementation of a replication-incompetent Trp motif mutant by
a plasmid encoding intact FIV Env. Construct D12 was mixed with plasmid
pcDNA3env, containing the intact env gene of FIV-Pet, or with an irrelevant
plasmid at equimolecular ratios, and the mixtures were used to transfect
CrFK cells, which were then processed as in Fig. 2. Cultures transfected
with the WT construct or left untreated served as controls. The virus-
containing supernatants harvested from all the cultures at day 5 were then
normalized for viral RNA content and assayed (A) for the ability to adsorb
to and (B) enter MBM cells, exactly as described in Fig. 4, as well as (C)
for the ability to replicate in a sustained fashion in these cells by measuring
RT production at days 4 (empty bars) and 8 (solid bars).
Table 2
Susceptibility of replication-competent Trp motif mutants to selected TM-
derived inhibitory peptides
Clone IC50 (Ag/ml) of peptide
Nb C8 Nd
WT 2.60 0.93 0.55
W770A 0.16 0.18 0.12
W773A 4.02 0.60 0.19
W776A 5.12 0.24 0.35
W770/776A 1.32 0.42 0.14
W773/776A 4.86 0.73 0.18
The synthetic peptides at final concentrations ranging from 0.05 to 50 Ag/ml
were assayed for inhibition of the indicated FIV clones exactly as described
(Giannecchini et al., 2003). Fifty percent inhibitory concentrations (IC50)
were calculated using the predicted exponential growth function in
Microsoft Excel. The experiment was repeated three times with comparable
results.
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clone was also similarly co-transfected as a positive control.
The resulting progeny viruses harvested at day 5 were then
normalized for viral RNA content and compared for ability
to bind, enter, and replicate in MBM cells. As depicted in
Figs. 6A and B, the progeny of construct D12 alone adsorbed
to cells in a near-normal fashion but generated little or no
proviral DNA. In contrast, the progeny of construct D12 co-
transfected with the intact Env-encoding plasmid both
adsorbed and generated proviral DNA at levels similar tothe WT control virus progeny. Furthermore, as expected for
virus particles resulting from a process of complementation,
the viral progeny generated by co-transfecting construct D12
with the intact Env-providing constructs was unable to
produce a sustained infection (Fig. 6C). These findings
clearly demonstrated that the lack of replication capacity of
the D12 mutant stemmed exclusively from its Env defect.
Sensitivity of the replication-competent Trp motif mutants to
inhibitory TM-derived peptides
Previous work had identified several synthetic peptides
modeled on different regions of the TM of FIV, which inhibit
in vitro replication of this virus with good efficiencies
(Giannecchini et al., 2003). Of special interest in the present
context, an N-terminal peptide (designated Nb) that contains
the amino acid sequence believed to interact with the Trp
motif in the course of the TM modifications accompanying
virus entry into cells (Giannecchini et al., 2003). We consid-
ered therefore of interest to determine the sensitivities of the
replication-competent Trp motif mutants W770A, W773A,
W776A, W770/776A, and W773/776A to inhibition by peptide
Nb. In parallel, the same viruses were also tested for suscep-
tibility to the inhibitory peptides C8 and Nd. C8 is an 8-mer
C-terminal peptide that contains the entire Trp motif and is
dependent on integrity of this motif for its activity while
peptide Nd is a 38-mer N-terminal peptide unrelated to the
putative target region of the Trp motif (Fig. 1). As shown in
Table 2, most of the mutants were inhibited by peptide Nb
with approximately the same efficiency as the WT clone.
Only W770A proved considerably more prone to Nb inhibi-
tion, as shown by a 16-fold reduced IC50. It is also notable
that the concentrations of peptide C8 and Nd that proved
necessary to inhibit the Trp motif mutants were instead
moderately but constantly reduced relative to the ones needed
for WT virus inhibition (Table 2), indicative of an enhanced
susceptibility of these mutants to cell-entry inhibitors in
general.
S. Giannecchini et al. / Virology 320 (2004) 156–166162Discussion
The molecular mechanisms that mediate FIV entry into
cells have been little investigated, but it is generally
assumed that they closely resemble the ones—much more
intensively studied—that are operative in HIV (Chan and
Kim, 1998; de Parseval and Elder, 2001; Doms and
Moore, 2001; Frey et al., 2001; Overbaugh et al., 2001;
Wyatt and Sodroski, 1998). The present study was promp-
ted by recent results of us showing that the short synthetic
peptide C8, of only eight amino acids, modeled on the
highly conserved Trp-rich pre-transmembrane region of the
FIV TM, potently inhibited the in vitro replication of all
the numerous FIV strains that were tested (Giannecchini et
al., 2003). Because there was evidence in such results that
this peptide blocked FIV entry by competing with the
corresponding region of naive virions, it was logical to
infer that the Trp-rich region might play a critical role in
FIV entry. Similarly located Trp-rich regions exist in the
TM of all lentiviruses, although they may differ somewhat
with regard to the number of Trp residues contained, the
length of the sequence in which these are interspersed, the
properties of the other amino acids present, and the
distances within the linear sequence of the Trp-residues
between themselves and with the putative membrane-
spanning domains (Fig. 7). In HIV, alterations of the Trp
region have been shown to impair or even block cell-to-
cell fusion and virus entry (Mun˜oz-Barroso et al., 1999;
Salzwedel et al., 1999). However, to our knowledge, until
the present one, there were no reported studies on the
functions of the Trp region of other lentiviruses.
Here, we examined whether modifications of the Trp
motif could affect the early interactions of FIV with suscep-
tible cells. To this purpose, we developed molecular clones
carrying selected mutations within this motif and investigat-
ed their ability to adsorb to and enter lymphoid cells. The
results can be summarized as follows:Fig. 7. Sequence alignment of the external pre-transmembrane domains of FIV TM
aligned by their membrane-spanning regions estimated by using ExPASy Molecula
number: M16575); VISNA, visna maedi virus (AAB25463); CAEV, caprine arth
(P19556); SIV, simian immunodeficiency virus (AAP46102); HIV-2 (AAC54473);
aromatic amino acids other than Trp; white boxes indicate hydrophobic amino ac1. As determined by counting the viral RNA genomes that
remained associated to cells after 2 h of contact at 4 jC,
none of the mutants significantly influenced the ability of
viral particles to adsorb to cells, regardless of how
drastically the integrity of the Trp motif was affected.
2. As judged by the failure to detect viral DNA in exposed
cells after 24 h of incubation at 37 jC, the three deletion
mutants studied were unable to proceed from adsorption
to provirus formation, regardless of whether the amino
acids removed were 4, 8, or 12 and included 2 or all 3 Trp.
3. A mutant that had the Trp motif scrambled, that is, of
regular length but most amino acids within the motif at
positions different from the parental WT, and a mutant
with all 3 Trp Ala-substituted also failed to generate
detectable provirus.
4. Of the mutants having 1 or 2 Trp substituted with Ala,
only W770/773A was totally unable to lead to the
production of proviral DNA. All the others generated
provirus at copy numbers similar (W770A) or approxi-
mately halved relative to the WT control.
5. All the mutants that had failed to generate provirus under
standard conditions of culture, produced substantial copy
numbers of viral DNAwhen the cultures were treated with
the fusing agent PEG, thus showing that their deficit was
restricted to the actual entry step. To the same conclusion
pointed also the observation that one of the mutants that
was studied under this respect (D12) had the deficit
overcome by complementation with an independent
source of intact Env. Notably, while in the presence of
PEG, the mutants generated fewer proviral copies than the
WT, this was not observed when complementation
provided intact Env, thus suggesting that PEG had
facilitated entry but had not entirely substituted for the
functions exerted in this process by the TM.
Taken together, these findings point to the conclusion
that an intact Trp motif is dispensable for normal or near-with the corresponding regions of selected lentiviruses. Sequences are hand
r Biology Server. EIAV, equine infectious anemia virus (GenBank accession
ritis encephalitis virus (AAA91829); BIV, bovine immunodeficiency virus
HIV-1 (AAB50262). Black boxes indicate Trp residues; gray boxes indicate
id; bold letters indicate charged amino acids.
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optimal FIV entry, thus confirming the indications emerged
from studying the inhibitory peptide C8 (Giannecchini et al.,
2003). In addition, the fact that only some alterations of this
motif—generally the most drastic ones—led to a complete
abrogation of entry demonstrates that FIV can tolerate
substantial degrees of change within the motif without
major losses in replication capacity. Support for the latter
concept comes also from the FIV replication curves that
were obtained by transfecting cells with mutated constructs.
Indeed, while the constructs that carried mutations that did
not allow virus entry gave virus replication curves indicative
that only the cycle of cell infection permitted by transfection
had occurred, the constructs that entered cells with reduced
efficacy gave sustained replication curves that, over the 1-
month observation period, were indistinguishable from the
WT or only moderately delayed, in spite that all the
introduced mutations were conserved in the viral progenies.
This, however, does not exclude that the presence of a WT
Trp motif provides an appreciable growth advantage in the
long run, thus possibly explaining the complete conserva-
tion of the motif among all the FIV isolates sequenced to
date.
The replication-competent mutant clones were also
compared with the WT for sensitivity to three selected
entry inhibitors modeled on different tracts of the FIV TM.
All exhibited a somewhat increased sensitivity to the two
inhibitory peptides C8 and Nd that are believed to target
the TM at sites different from the Trp motif (Giannecchini
et al., 2003), suggesting that their reduced ability to enter
cells may have rendered them more prone to blocking of
entry. In contrast, when tested against peptide Nb, which
contains the sequence partially overlapping the fusion
peptide that is believed to interact with the Trp motif
(Giannecchini et al., 2003), most mutants showed an
unchanged sensitivity, thus suggesting that their defective
Trp motifs had reduced affinity for the Nb peptide and that
this compensated the entry deficit. That mutant W770A
proved instead more sensitive than the WT to peptide Nb
might therefore imply that the Trp at position 770 is of
little weight in determining how effectively this peptide
interacts with the Trp motif. In this context, it is also worth
commenting on a conflict that might appear to exist
between the present observation that the Trp motif of
FIV can tolerate Ala-substitutions of up to two of its three
Trp residues with no much loss in infectivity and previous
findings showing that the antiviral activity of the Trp
motif-derived peptide C8 was completely abrogated if just
one of three Trp was Ala-substituted (Giannecchini et al.,
2003). We have previously presented evidence that con-
servation of all Trp is important for conferring peptide C8
a conformational propensity toward a helical structure and
that such a structure is crucial for the peptide C8 to be
active (Giannecchini et al., 2003). In the much more
complex native TM molecule, the Trp motif might not
be strictly dependent on a specific conformation to remainfunctional or, if a specific conformation is required, this
might be maintained by other forms of constrain that are
unthinkable in a short, 8-mer peptide.
The present results permit to exclude that the function of
the Trp motif of FIV is merely that of a molecular spacer
within the TM, as shown by lack of entry of the mutants
having this motif scrambled or all three Trp residues in the
motif Ala-substituted. They have also established the min-
imum requirement in Trp residues for suboptimal FIV entry,
by demonstrating that conservation of only one Trp residue
at positions 770 or 773 was sufficient for entry albeit at
reduced levels, although the concomitant presence of both
Trp773 and Trp776 allowed entry at WT levels. The current
data do not, however, permit to address where exactly the
Trp motif intervenes in FIV entry. According to current
models for HIV entry (Chan and Kim, 1998; Doms and
Moore, 2001; Lawless et al., 1996; Melikyan et al., 2000;
Mun˜oz-Barroso et al., 1998; and reviewed in Gallo et al.,
2003), thanks to the high preference of Trp residues for
residing at the external face of membranes (Schibli et al.,
2001; Sua´rez et al., 2000a, 2000b; Wimley and White,
1996; Yau et al., 1998), the pre-transmembrane Trp-rich
region would appear to reside on the Env surface at the
membrane–water interface of the lipid bilayer. Following
TM activation, the Trp-rich region is believed to undergo
sequential conformation transitions, from a closed turn to an
extended arrangement and finally to an amphipathic helical
structure capable of intimately interacting with the viral
membrane through some Trp residues and, concomitantly,
with the cell membrane through others (Barbato et al.,
2003). With their relatively bulky indole side chains, the
Trp residues, most likely synergizing with the fusion pep-
tide (Sua´rez et al., 2000a), would then destabilize both
membranes and drive the energetically unfavorable lipid
merging that permits the formation and expansion of the
fusion pore in the late stages of the entry process (Melikyan
et al., 2000; Peisajovich and Shai, 2003). It should, how-
ever, be born in mind that in spite of a common structural
framework (Pancino et al., 1993, 1995; Serres, 2000) that
hints to similar modes of action, the TM of FIV and HIV
presents considerable dissimilarities both within the Trp-
rich domains and within other regions, and that these
dissimilarities might determine significant mechanistic dif-
ferences in the way they function. A detailed understanding
of how the various members of this important family of
viral molecules work would certainly create new opportu-
nities to prevent and treat infections.Material and methods
Cell cultures
The CrFK and the IL2-dependent T lymphoid MBM cell
lines were propagated using the routine procedures of our
laboratory (Bendinelli et al., 2001; Pistello et al., 2002).
irology 320 (2004) 156–166WT and mutated plasmids
The Trp motif mutant plasmids were produced starting
from a WT construct developed in a previous study (Bend-
inelli et al., 2001) that had been derived from p34TF10
(kindly provided by Dr. J.H. Elder; La Jolla, CA, GenBank
accession number: NC001482). Both substitutions and dele-
tions were created by PCR (protocols and primers available
by e-mail on request) to generate overlapping fragments that
were then joined together to produce the desiderated muta-
genized TM segments. The resulting amplicons were checked
by cycle sequencing for inserted mutations, digested with
SpeI (restriction site nucleotide position 8285, as referred to
p34TF10; New England Biolabs, Beverly, MA) and AsuII
(8917, MBI Fermentas, Vilnius, LT), and reinserted into the
WT backbone previously digested with the same enzymes
and dephosphorylated. Mutant clones were finally expanded
and checked again for mutations before transfection.
The intact FIV Env-encoding plasmid used in the com-
plementation experiment was obtained by cloning the entire
env from p34TF10 into the pCDNA3 plasmid vector (Invi-
trogen, Milan, Italy). To render env expression Rev-indepen-
dent, the constitutive transport element of Mason-Pfizer
monkey virus was cloned downstream the inserted gene
(Bray et al., 1994).
Transfections
Mutant clones were transfected into CrFK cells by the
calcium phosphate method and propagated in MBM cells
added immediately thereafter. Viral progenies were moni-
tored by assaying for RT activity and for FIV Gag p25 and
RNA contents the culture supernatants at different times
post-transfection.
FIV RNA quantitation
The numbers of FIV RNA copies were determined by
real-time Taq-Man-PCR (rt-TM-PCR; Pistello et al., 2002).
Briefly, RNA was extracted from the cells or culture super-
natants with the RNeasy Mini Kit or QIAamp Viral RNA
Kit, respectively (Qiagen, Milan, Italy). Viral RNA was
reverse-transcribed with 900 nM antisense primer PU8-AS
(1467–1493), and cDNA amplified by TM-PCR on the ABI
Prism 7700 Sequence Detection System instrument (Perkin-
Elmer/Applied Biosystems, Monza, Italy) with the Univer-
sal PCR Master Mix (Perkin-Elmer/Applied Biosystems),
900 nM sense PU8-S (1375–1397), and 200 nM probe
PU8-P (1425–1453). Amplification was carried out in 50
Al by the default cycle. Samples tested in duplicate and
negative and positive controls in triplicate, and a few no-
template controls were also interspersed randomly in each
amplification plate. Serial 10-fold dilutions of gag p25 RNA
transcripts were used to produce a standard curve. Intra- and
interassay precision and reproducibility of the assay were
assessed as described (Giannecchini et al., 2002). The
S. Giannecchini et al. / V164sensitivity of the assay was 200 copies/ml plasma, as
evaluated by extracting and amplifying FIV-negative plasma
spiked with serial 10-fold dilutions of pGEM-Pet RNA
transcripts.
Proviral load quantitation
Genomic DNA was extracted from MBM cells using the
QIAamp DNA Blood Mini Kit (Qiagen) and analyzed for
provirus copy number by rt-TM-PCR under the conditions
described above, except that the reaction volume was 25 Al.
Serial 10-fold dilutions (101 to 107) of p34TF10 in a
background of 1 Ag of genomic DNA were used to produce
a standard curve and determine the lowest limit of detection
(10 copies).
Cycle sequencing
The presence of the desiderated mutations in the plasmid
constructs was verified by amplifying the encompassing env
segment with TM-S (8096–8120) and LPCR-AS (9069–
9046) primers and cycle sequencing with Pet161S (8275–
8297) and Pet92AS (8997–8972) primers. Sequencing reac-
tions were run and data analyzed on the automated ALF
DNA sequencer (Amersham Pharmacia Biotech, Cologno
Monzese, Italy). In the case of viral progenies, the same
analysis was conducted by reverse-transcribing the RNA
released into culture supernatants with LPCR-AS before
amplification.
Miscellaneous assays
RT activity and FIV capsid antigen p25 in the culture
fluids were measured by ELISA methods, exactly as de-
scribed (Giannecchini et al., 2002; Mazzetti et al., 1999).
FIV glycoprotein detection in the culture fluids was carried
out using an ELISA exploiting Galanthus nivalis lectin-
coated wells as described (Mazzetti et al., 1999). Western
blotting analysis of the FIV components present in culture
fluids was performed by pelleting, electrophoresing on 10%
SDS-PAGE, probing with FIV-immune cat serum or anti-
FIV Env monoclonal antibody 71.2 (kindly provided by Dr.
M. J. Hosie, Glasgow, UK), and then staining with peroxi-
dase-conjugated anti-feline or anti-mouse IgG polyclonal
antibody (Giannecchini et al., 2002). FIV infectivity was
measured by using MBM cells as substrate and testing the
supernatant fluids for p25 at day 8 post-inoculation. The
virus inhibitory activity of synthetic peptides was tested
against 10 TCID50 of FIV clones by using MBM cells as
substrate exactly as described (Giannecchini et al., 2003).Acknowledgments
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